Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

O60218 (AK1BA_HUMAN) Homo sapiens (Human)

Aldo-keto reductase family 1 member B10 UniProtKBInterProSTRINGInteractive Modelling

316 aa; Sequence (Fasta)

Available Structures

20 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal Structure Of AKR1B10 Complexed With NADP+ And Tolrestatmonomer1-316
NAP;TOL;
Assess
Crystal structure of human AKR1B10 complexed with NADP+ and sulindacmonomer1-316
NAP;SUZ;
Assess
Crystal structure of human AKR1B10 complexed with NADP+ and the synthetic retinoid UVI2008monomer1-316
NAP;UV8;EDO;
Assess
Human AKR1B10 mutant V301L complexed with NADP+ and fidarestatmonomer1-316
NAP;FID;CL;
Assess
Crystal structure of the methylated K125R/V301L AKR1B10 Holoenzymemonomer1-316
NAP;EDO;
Assess
Crystal structure of human AKR1B10 complexed with NADP+ and JF0049monomer1-316
NAP;F49;EDO;
Assess
Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK319monomer1-316
NAP;1WX;EDO;
Assess
Crystal structure of the methylated wild-type AKR1B10 holoenzymemonomer1-316
NAP;EDO;
Assess
Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor IDD388monomer1-316
NAP;388;EDO;
Assess
Crystal structure of human AKR1B10 complexed with NADP+ and JF0064monomer1-316
NAP;64I;
Assess
Crystal structure of AKR1B10 complexed with NADP+monomer1-316
NAP;
Assess
Human AKR1B10 mutant V301L complexed with NADP+ and sorbinilmonomer1-316
NAP;SBI;
Assess
Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK184monomer1-316
NAP;MK4;EDO;
Assess
Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK181monomer1-316
NAP;W8X;EDO;
Assess
Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK204monomer1-316
NAP;DQP;EDO;
Assess
Crystal structure of AKR1B10 complexed with NADP+ and Caffeic acid phenethyl estermonomer1-316
QAP;NAP;
Assess
Crystal Structure Of AKR1B10 Complexed With NADP+ And Flufenamic acidmonomer1-316
FLF;NAP;
Assess
Crystal Structure Of AKR1B10 Complexed With NADP+ And Zopolrestatmonomer1-316
NAP;ZST;NA;
Assess
Crystal Structure Of AKR1B10 Complexed With NADP+ And Epalrestatmonomer1-316
EPR;NAP;
Assess
Crystal structure of AKR1B10 in complex with NADP+ and Androst-4-ene-3-beta-6-alpha-diolmonomer4-316
NAP;8QL;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
4ga8.1.Amonomer0.871-316
NAP;99.68
Assess